Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ATUL - Investment Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Investment List

πŸ“Š Investment Rating: 3.6

Here’s a comprehensive breakdown of Atul Ltd. based on your parameters

🧠 Fundamental Analysis

Valuation

Stock P/E (39.5) vs Industry P/E (34.4) β†’ Slightly overvalued

PEG Ratio (-6.50) β†’ Negative PEG suggests earnings growth is not keeping pace with valuation

Price to Book (β‰ˆ3.5) β†’ Reasonable, but not cheap

Profitability

ROE (9.10%) and ROCE (12.8%) β†’ Moderate returns, not exceptional for long-term compounding

EPS (β‚Ή170) β†’ Strong earnings base

Dividend Yield (0.37%) β†’ Low, not ideal for income-focused investors

Debt to Equity (0.04) β†’ Excellent financial health, almost debt-free

πŸ“ˆ Technical & Trend Indicators

Current Price (β‚Ή6,719) is below both DMA 50 (β‚Ή7,033) and DMA 200 (β‚Ή6,800) β†’ Bearish trend

RSI (35.4) β†’ Near oversold zone, potential for technical bounce

MACD (-158) β†’ Strong bearish momentum

Volume is below average β†’ Weak participation

🏁 Ideal Entry Price Zone

Based on valuation and technicals

β‚Ή6,300–₹6,500 would be a more attractive entry zone

This aligns with support near 200 DMA and RSI oversold levels

🧳 Exit Strategy / Holding Period

If you already hold the stock

Holding Period: Minimum 3–5 years to allow for cyclical recovery and margin expansion

Exit Strategy

Partial exit if price crosses β‚Ή8,000+ and valuation remains stretched

Hold if ROE/ROCE improve and PEG turns positive

Reassess if fundamentals deteriorate or price breaks below β‚Ή6,000

πŸ§ͺ Final Verdict

Atul Ltd. is a financially sound but moderately overvalued stock with subdued growth metrics. It’s not a top-tier long-term compounder at current levels, but could be a decent pick if accumulated near support zones and held patiently.

Would you like a comparison with peers in the specialty chemicals space?

Edit in a page

Back to Investment List